Cartography raises $67 million in Series B financing led by Pfizer Ventures to advance its oncology pipeline, including the lead program CBI-1214 into Phase 1 trials.
Amount Raised
$67 Million
Round Type
Series B
South San FranciscoBiotechnologyInvestors
Description
Cartography Biosciences, Inc. has secured $67 million in Series B financing to support its oncology programs. The funding will help advance its lead program, CBI-1214, into the clinic. Pfizer Ventures led the round, joined by other investors like LG Corp and Amgen Ventures
Quick answer
Cartography Biosciences raised $67 Million in a Series B round, dated October 2, 2025. Investors: Lotte Holdings Cvc, Andreessen Horowitz (a16z) Bio + Health, 8VC, Artis Ventures, Global BioAccess Fund, LG Corp, Amgen Ventures and Finchley H.V. Cartography Biosciences is based in South San Francisco, California, United States.
- How much did Cartography Biosciences raise?
- Cartography Biosciences raised $67 Million in a Series B round on October 2, 2025.
- Who invested in Cartography Biosciences?
- Lotte Holdings Cvc, Andreessen Horowitz (a16z) Bio + Health, 8VC, Artis Ventures, Global BioAccess Fund, LG Corp, Amgen Ventures and Finchley H.V. are named as investors in this round.
- What does Cartography Biosciences do?
- Cartography Biosciences is building a differentiated oncology pipeline of antibody-based therapies designed to target tumors more precisely than existing therapeutics.
- Where is Cartography Biosciences based and how big is it?
- Cartography Biosciences is based in South San Francisco, California, United States. Fundz records about 63 employees.
- Who are the decision-makers at Cartography Biosciences?
- Fundz holds 1 contact at Cartography Biosciences, including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Cartography Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Fang Oral Care raised $1.1M (Funding Round) on November 15, 2025.
- Conexeu Sciences raised $202K on November 14, 2025.
- TandemAI raised $22M (Series A) on November 14, 2025.
- Red Queen Bio raised $15M (Seed) on November 14, 2025.
- Annexon raised $65M (Post-IPO Equity) on November 14, 2025.
- Repair Biotechnologies raised $5.3M on November 14, 2025.
Who to call at Cartography Biosciences, and when
A new round usually means Cartography Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cartography Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cartography Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cartography Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cartography Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCartography Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.